Infosys Ltd
BSE:500209
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Infosys Ltd
BSE:500209
|
IN |
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
IE |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
Atlantic Sapphire ASA
OSE:ASA
|
NO |
|
KB Financial Group Inc
NYSE:KB
|
KR |
|
B
|
Boosh Plant Based Brands Inc
CNSX:VEGI
|
CA |
|
Shanghai CDXJ Digital Technology Co Ltd
SSE:603887
|
CN |
|
Starpharma Holdings Ltd
ASX:SPL
|
AU |
|
Exide Industries Ltd
NSE:EXIDEIND
|
IN |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
Canopy Growth Corp
TSX:WEED
|
CA |
|
Whirlpool Corp
NYSE:WHR
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
Arafura Resources Ltd
ASX:ARU
|
AU |
Wall St Price Targets
INFY Price Targets Summary
Infosys Ltd
According to Wall Street analysts, the average 1-year price target for INFY is 1 519.61 INR with a low forecast of 1 246.83 INR and a high forecast of 1 910.2 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INFY's stock price target?
Price Target
1 519.61
INR
According to Wall Street analysts, the average 1-year price target for INFY is 1 519.61 INR with a low forecast of 1 246.83 INR and a high forecast of 1 910.2 INR.
What is the Revenue forecast for Infosys Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 7%.
What is the Operating Income forecast for Infosys Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 7 years is 8%.
What is the Net Income forecast for Infosys Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 7%.
